About Altacor Pharma
Altacor Pharma is a company based in Cambridge (United Kingdom) founded in 2006 was acquired by Fidia Farma in September 2025.. Altacor Pharma has raised $3.06 million across 2 funding rounds from investors including Fidia Farma, Enterprise Ventures and Clive Austin. Altacor Pharma offers products and services including Clinitas Drops, Clinitas Gel, BioLon, and Clinitas Antibacterial Eye Compress. Altacor Pharma operates in a competitive market with competitors including Kriya Therapeutics, Annexon, Aldeyra, Nicox and Gyroscope, among others.
- Headquarter Cambridge, United Kingdom
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Altacor Limited
- Date of Incorporation 12 Apr, 2005
- Jurisdiction WINDSOR, BERKSHIRE, ENGLAND
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$3.06 M (USD)
in 2 rounds
-
Latest Funding Round
$3.06 M (USD), Series A
Feb 08, 2011
-
Investors
Fidia Farma
& 4 more
-
Employee Count
Employee Count
- Acquired by
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Altacor Pharma
Altacor Pharma offers a comprehensive portfolio of products and services, including Clinitas Drops, Clinitas Gel, BioLon, and Clinitas Antibacterial Eye Compress. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Provides relief for dry eye conditions through lubricating drops.
Offers hydration for severe dry eye symptoms.
Used as viscoelastic device in ophthalmic surgery procedures.
Helps alleviate symptoms of blepharitis and eye irritation.
Funding Insights of Altacor Pharma
Altacor Pharma has successfully raised a total of $3.06M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $3.06 million completed in February 2011. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Series A — $3.1M
- First Round First Round
- Investors Count 4
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb, 2011 | Amount | Series A - Altacor Pharma | Valuation | Clive Austin | |
| Jun, 2010 | Amount | Seed - Altacor Pharma | Valuation | Esperante |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Altacor Pharma
Altacor Pharma has secured backing from 5 investors, including venture fund, angel, and institutional investors. Prominent investors backing the company include Fidia Farma, Enterprise Ventures and Clive Austin. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early and Growth stage Venture Debt firm that does debt investments in the UK
|
Founded Year | Domain | Location | |
|
Tax-efficient investment opportunities are provided by ProVen for retail investors.
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Altacor Pharma
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Altacor Pharma
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Altacor Pharma Comparisons
Competitors of Altacor Pharma
Altacor Pharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Kriya Therapeutics, Annexon, Aldeyra, Nicox and Gyroscope, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of therapeutic solutions for the treatment of diabetes
|
|
| domain | founded_year | HQ Location |
Developer of antibodies to treat complement-mediated neurodegenerative diseases
|
|
| domain | founded_year | HQ Location |
Drug candidates for immune-mediated diseases are developed by Aldeyra.
|
|
| domain | founded_year | HQ Location |
Nitric oxide-based therapeutics for glaucoma and eye conditions are developed.
|
|
| domain | founded_year | HQ Location |
Mobile SDK developed for app engagement and monetization strategies.
|
|
| domain | founded_year | HQ Location |
Gene therapies for ocular and neurodegenerative diseases are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Altacor Pharma
Frequently Asked Questions about Altacor Pharma
When was Altacor Pharma founded?
Altacor Pharma was founded in 2006 and raised its 1st funding round 4 years after it was founded.
Where is Altacor Pharma located?
Altacor Pharma is headquartered in Cambridge, United Kingdom. It is registered at Cambridge, Cambridgeshire, United Kingdom.
Is Altacor Pharma a funded company?
Altacor Pharma is a funded company, having raised a total of $3.06M across 2 funding rounds to date.
What does Altacor Pharma do?
Altacor develops ophthalmic products for dry-eye, glaucoma, glaucoma surgery and ocular surgery. Products include clinitas and clinitas GEL, prescription products for the treatment of moderate dry eye; Clinitas Range, for treating major causes of dry eye; Blepharitis Range loosens and removes Meibomian secretions; and Ocular supplements like EyeBar, a chocolate bar containing AREDS2 formula for the maintenance of healthy vision. The companys RD pipeline covers products for eye surgery and glaucoma. The company was acquired by Esperante in 2014.
Who are the top competitors of Altacor Pharma?
Altacor Pharma's top competitors include Annexon, Alimera Sciences and MeiraGTx.
What products or services does Altacor Pharma offer?
Altacor Pharma offers Clinitas Drops, Clinitas Gel, BioLon, and Clinitas Antibacterial Eye Compress.
Who are Altacor Pharma's investors?
Altacor Pharma has 5 investors. Key investors include Fidia Farma, Enterprise Ventures, Clive Austin, ProVen, and Esperante.